Hemophilia A Drug Market Report

China Hemophilia A Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 11, 2023
  • PAGES：146
  • REPORT CODE：GMM1793546
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Factor VIII procoagulant component (VIII: C) deficiency, also known as AGH deficiency, is a sexually associated recessive genetic disease, transmitted by women, and male.

    This report elaborates on the current development of the Hemophilia A Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Inspiration Biopharmaceuticals

    • Biogen Idec

    • Catalyst Biosciences

    • Dimension Therapeutics

    • Baxter International

    • CSL Behring

    • Emergent BioSolutions

    • Grifols

    • Dong-A Socio

    • Novo Nordisk

    • Pfizer

    • Amarna Therapeutics

    • Bayer's

    By Type:

    • Antifibrinolytic Agents

    • Recombinant Coagulation Factor Concentrates

    • Desmopressin

    • Plasma Derived Coagulation Factor Concentrates

    By Application:

    • Hospital Pharmacies

    • Others

    • Retail Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hemophilia A Drug Market Overview 2018-2029

    • 1.1 China Hemophilia A Drug Industry Development Overview

    • 1.2 China Hemophilia A Drug Industry Development History

    • 1.3 China Hemophilia A Drug Industry Market Size (2018-2029)

    • 1.4 China Hemophilia A Drug Market Analysis by Type from Production Side

      • 1.4.1 China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Antifibrinolytic Agents (2018-2029)

      • 1.4.2 China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Recombinant Coagulation Factor Concentrates (2018-2029)

      • 1.4.3 China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Desmopressin (2018-2029)

      • 1.4.4 China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Plasma Derived Coagulation Factor Concentrates (2018-2029)

    • 1.5 China Hemophilia A Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.2 China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • 1.6 China Hemophilia A Drug Market Analysis by Region

      • 1.6.1 North China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hemophilia A Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hemophilia A Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hemophilia A Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Hemophilia A Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hemophilia A Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hemophilia A Drug Industry Development

    Chapter 3 Hemophilia A DrugIndustry Chain Analysis

    • 3.1 Hemophilia A Drug Industry Chain

    • 3.2 Hemophilia A Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hemophilia A Drug Market

    • 3.3 Hemophilia A Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hemophilia A Drug Market

    Chapter 4 China Hemophilia A Drug Market, by Type

    • 4.1 China Hemophilia A Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hemophilia A Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hemophilia A Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Hemophilia A Drug Production Volume and Growth Rate of Antifibrinolytic Agents

      • 4.5.2 China Hemophilia A Drug Production Volume and Growth Rate of Recombinant Coagulation Factor Concentrates

      • 4.5.3 China Hemophilia A Drug Production Volume and Growth Rate of Desmopressin

      • 4.5.4 China Hemophilia A Drug Production Volume and Growth Rate of Plasma Derived Coagulation Factor Concentrates

    Chapter 5 China Hemophilia A Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hemophilia A Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hemophilia A Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Hemophilia A Drug Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.2 China Hemophilia A Drug Market Size and Growth Rate of Others

      • 5.5.3 China Hemophilia A Drug Market Size and Growth Rate of Retail Pharmacies

    Chapter 6 China Hemophilia A Drug Market, by Region

    • 6.1 China Hemophilia A Drug Production Volume and Production Value, by Region

    • 6.2 China Hemophilia A Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Hemophilia A Drug Market Analysis

    • 7.1 North China Hemophilia A Drug Market, by Type

    • 7.2 North China Hemophilia A Drug Market, by Application

    Chapter 8 Central China Hemophilia A Drug Market Analysis

    • 8.1 Central China Hemophilia A Drug Market, by Type

    • 8.2 Central China Hemophilia A Drug Market, by Application

    Chapter 9 South China Hemophilia A Drug Market Analysis

    • 9.1 South China Hemophilia A Drug Market, by Type

    • 9.2 South China Hemophilia A Drug Market, by Application

    Chapter 10 East China Hemophilia A Drug Market Analysis

    • 10.1 East China Hemophilia A Drug Market, by Type

    • 10.2 East China Hemophilia A Drug Market, by Application

    Chapter 11 Northeast China Hemophilia A Drug Market Analysis

    • 11.1 Northeast China Hemophilia A Drug Market, by Type

    • 11.2 Northeast China Hemophilia A Drug Market, by Application

    Chapter 12 Southwest China Hemophilia A Drug Market Analysis

    • 12.1 Southwest China Hemophilia A Drug Market, by Type

    • 12.2 Southwest China Hemophilia A Drug Market, by Application

    Chapter 13 Northwest China Hemophilia A Drug Market Analysis

    • 13.1 Northwest China Hemophilia A Drug Market, by Type

    • 13.2 Northwest China Hemophilia A Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Inspiration Biopharmaceuticals

        • 14.1.1 Inspiration Biopharmaceuticals Company Profile

        • 14.1.2 Inspiration Biopharmaceuticals Hemophilia A Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Biogen Idec

        • 14.2.1 Biogen Idec Company Profile

        • 14.2.2 Biogen Idec Hemophilia A Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Catalyst Biosciences

        • 14.3.1 Catalyst Biosciences Company Profile

        • 14.3.2 Catalyst Biosciences Hemophilia A Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Dimension Therapeutics

        • 14.4.1 Dimension Therapeutics Company Profile

        • 14.4.2 Dimension Therapeutics Hemophilia A Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Baxter International

        • 14.5.1 Baxter International Company Profile

        • 14.5.2 Baxter International Hemophilia A Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 CSL Behring

        • 14.6.1 CSL Behring Company Profile

        • 14.6.2 CSL Behring Hemophilia A Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Emergent BioSolutions

        • 14.7.1 Emergent BioSolutions Company Profile

        • 14.7.2 Emergent BioSolutions Hemophilia A Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Grifols

        • 14.8.1 Grifols Company Profile

        • 14.8.2 Grifols Hemophilia A Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Dong-A Socio

        • 14.9.1 Dong-A Socio Company Profile

        • 14.9.2 Dong-A Socio Hemophilia A Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Novo Nordisk

        • 14.10.1 Novo Nordisk Company Profile

        • 14.10.2 Novo Nordisk Hemophilia A Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pfizer

        • 14.11.1 Pfizer Company Profile

        • 14.11.2 Pfizer Hemophilia A Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Amarna Therapeutics

        • 14.12.1 Amarna Therapeutics Company Profile

        • 14.12.2 Amarna Therapeutics Hemophilia A Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Bayer's

        • 14.13.1 Bayer's Company Profile

        • 14.13.2 Bayer's Hemophilia A Drug Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hemophilia A Drug Industry Research Conclusions

    • 15.2 Hemophilia A Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hemophilia A Drug Industry Market Size (2018-2029)

    • Figure China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Antifibrinolytic Agents (2018-2029)

    • Figure China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Recombinant Coagulation Factor Concentrates (2018-2029)

    • Figure China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Desmopressin (2018-2029)

    • Figure China Hemophilia A Drug Production Volume, Production Value and Growth Rate of Plasma Derived Coagulation Factor Concentrates (2018-2029)

    • Figure China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Hemophilia A Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure North China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hemophilia A Drug Market Size and Growth Rate from 2018-2029

    • Figure Hemophilia A Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hemophilia A Drug Market Share by Type in 2018

    • Figure China Hemophilia A Drug Market Share by Type in 2023

    • Figure China Hemophilia A Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hemophilia A Drug Production Volume and Growth Rate of Antifibrinolytic Agents (2018-2023)

    • Figure China Hemophilia A Drug Production Volume and Growth Rate of Recombinant Coagulation Factor Concentrates (2018-2023)

    • Figure China Hemophilia A Drug Production Volume and Growth Rate of Desmopressin (2018-2023)

    • Figure China Hemophilia A Drug Production Volume and Growth Rate of Plasma Derived Coagulation Factor Concentrates (2018-2023)

    • Figure China Hemophilia A Drug Market Share by Application in 2018

    • Figure China Hemophilia A Drug Market Share by Application in 2023

    • Figure China Hemophilia A Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Hemophilia A Drug Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Hemophilia A Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Hemophilia A Drug Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Table China Hemophilia A Drug Production Volume by Region (2018-2023)

    • Table China Hemophilia A Drug Production Volume Share by Region (2018-2023)

    • Figure China Hemophilia A Drug Production Volume Share by Region (2018-2023)

    • Table China Hemophilia A Drug Production Value by Region (2018-2023)

    • Table China Hemophilia A Drug Production Value Share by Region (2018-2023)

    • Figure China Hemophilia A Drug Production Value Share by Region (2018-2023)

    • Table China Hemophilia A Drug Sales Volume by Region (2018-2023)

    • Table China Hemophilia A Drug Sales Volume Share by Region (2018-2023)

    • Figure China Hemophilia A Drug Sales Volume Share by Region (2018-2023)

    • Table China Hemophilia A Drug Sales Value by Region (2018-2023)

    • Table China Hemophilia A Drug Sales Value Share by Region (2018-2023)

    • Figure China Hemophilia A Drug Sales Value Share by Region (2018-2023)

    • Table North China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table North China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure North China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table North China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table North China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table Central China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table Central China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table Central China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table South China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table South China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure South China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table South China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table South China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table East China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table East China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure East China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table East China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table East China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table Northeast China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table Southwest China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hemophilia A Drug Production Volume by Type (2018-2023)

    • Table Northwest China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hemophilia A Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Hemophilia A Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hemophilia A Drug Sales Volume Share by Application (2018-2023)

    • Table Inspiration Biopharmaceuticals Company Profile

    • Table Inspiration Biopharmaceuticals Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Catalyst Biosciences Company Profile

    • Table Catalyst Biosciences Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Dimension Therapeutics Company Profile

    • Table Dimension Therapeutics Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Baxter International Company Profile

    • Table Baxter International Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table CSL Behring Company Profile

    • Table CSL Behring Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions Company Profile

    • Table Emergent BioSolutions Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Grifols Company Profile

    • Table Grifols Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Dong-A Socio Company Profile

    • Table Dong-A Socio Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Amarna Therapeutics Company Profile

    • Table Amarna Therapeutics Hemophilia A Drug Revenue, Price and Gross (2018-2023)

    • Table Bayer's Company Profile

    • Table Bayer's Hemophilia A Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US